Novel analytical methodologies, real-world data (RWD), innovative trial designs, and new technologies are crucial to optimise ...

US District Judge William Alsup's restraining order has been granted on the grounds that the Office of Personnel Management ...

There is huge unmet need for new rare disease therapies, where patients have few or no available options. According to the ...

I envision Chiesi as a proactive leader driving innovation and collaboration within the rare disease community. Our goal is ...

For any company developing AI-powered solutions, the “why” should guide every decision. The technical sophistication of your ...

Other companies use customer reference and patient data to improve operational agility as they launch and scale their first ...

Ten out of 11 children with a form of congenital deafness who were treated with an experimental gene therapy developed by ...

Eikon Therapeutics has added to its already copious cash reserves with a $351 million fourth-round financing to fund a ...

"Many loss of pulse incidents happen when the person is alone, leaving them with effectively no chance of receiving ...

Keytruda has been approved since 2016 as a second-line option after chemotherapy for patients with more advanced HNSCC that ...

The change in leadership comes shortly after Indivior warned that it is expecting a sharp decline in its revenues in 2025, ...

JAK inhibitor Rinvoq (upadacitinib) has been backed by the CHMP as a 15mg, once-daily treatment for adults with GCA, an ...